
Deep Intelligent Pharma provides pharma companies an AI-driven platform to accelerate drug discovery and development and move compounds from lab to market faster and with higher quality. The company delivers an end-to-end B2B SaaS platform using advanced artificial intelligence models and data science applied to medicinal chemistry, preclinical development, and regulatory workflows. DIP's technology stack centers on machine learning and predictive modeling, supporting integrations with typical drug R&D processes and serving pharmaceutical R&D teams and biotech firms. The company operates internationally with presence in China, the United States and Japan.

Deep Intelligent Pharma provides pharma companies an AI-driven platform to accelerate drug discovery and development and move compounds from lab to market faster and with higher quality. The company delivers an end-to-end B2B SaaS platform using advanced artificial intelligence models and data science applied to medicinal chemistry, preclinical development, and regulatory workflows. DIP's technology stack centers on machine learning and predictive modeling, supporting integrations with typical drug R&D processes and serving pharmaceutical R&D teams and biotech firms. The company operates internationally with presence in China, the United States and Japan.